Topic

Articles

Insights from sponsors conducting global DCTs and provide guidance for how best to plan and execute effective eCOA strategies.

Perspectives and Guidance for Effective eCOA in Global DCTs

Elizabeth Rickenbacher, PhD, Director of Strategy for 4G Clinical discusses changes in the IRT and RTSM solutions.

The State of IRT and RTSM Technologies 

Denis Polyanskiy, founder of Trialcome, discusses how the industry can overcome issues with non-adherence.

Addressing Medication Adherence Challenges

Jeff Wiley, head of oncology, global clinical project delivery at Labcorp Drug Development, sheds light on how Labcorp Drug Development is using remote monitoring to advance the industry toward new levels of connectivity.

Labcorp Drug Development Expands Remote Monitoring for Better Collaboration with Sites

To derive the greatest benefits from eCOA technology, several elements must work together to create a strong foundation for sponsor success.

Thoughtful Design in eCOA Development: Part 2

While Case Report Forms are a main contributor to collected data, non-CRF data such as core laboratory data and central imaging can be critical to any clinical study.

Establishing Metrics and Standardization for Non-CRF Data in EDC

Four lessons learned from changes made by research sites during the pandemic to drive long-term success.

Accelerating Research Site Operations: Lessons from the University of Louisville

A discussion of the regulatory history behind audit trails and its interpretation as it relates to clinical research data originating or residing in EDC or eCOA systems.

When Should the Audit Trail Begin?

Charles Sydnor, CCRA, ACRP-CP, project manager at Crofoot, discusses how offering a digital patient experience in trials enables the site to provide better patient care.

Shifting from Paper to Digital Patient Consent

There's no one-size-fits-all approach during the COVID-19 pandemic 

eClinical